Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
Search
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News Releases view all

    • News in Focus
        • Browse News Releases

        • All News Releases
        • All Public Company
        • English-only
        • News Releases Overview

        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
        • Multimedia Gallery Overview

        • Trending Topics

        • All Trending Topics
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • Auto & Transportation Overview

        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • Business Technology Overview

        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • Financial Services & Investing Overview

        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • General Business Overview

        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • Consumer Technology Overview

        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • Energy & Natural Resources Overview

        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • Environment Overview

        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • Heavy Industry & Manufacturing Overview

        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • Telecommunications Overview

        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • Consumer Products & Retail Overview

        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • Entertainment & Media Overview

        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • Health Overview

        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • Sports Overview

        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • Travel Overview

        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • Policy & Public Interest Overview

        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • People & Culture Overview

        • View All People & Culture

    • Explore Our Platform
    • Plan Campaigns
    • Create with AI
    • Distribute Press Releases
    • Report Results
    • Amplify Content
    • All Products
    • General Inquiries
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices
    • Hamburger menu
    • PR Newswire: news distribution, targeting and monitoring
    • Send a Release
      • ALL CONTACT INFO
      • Contact Us

        888-776-0942
        from 8 AM - 10 PM ET

    • Searching for your content...

      No results found. Please change your search terms and try again.

      News Releases

      view all
      Close menu
    • News
    • Products
    • Contact
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • 3 News in Focus
      • 5 Business & Money
      • 5 Science & Tech
      • 5 Lifestyle & Health
      • 1 Policy & Public Interest
      • 1 People & Culture
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content
      • All Products
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices
      • Send a Release
      • Client Login
      • Resources
      • Blog
      • Journalists
      • RSS
      Close submenu (News in Focus) News in Focus
      • Browse News Releases
      • Multimedia Gallery
      • Trending Topics
      Close submenu (Business & Money) Business & Money
      • Auto & Transportation
      • Business Technology
      • Entertain­ment & Media
      • Financial Services & Investing
      • General Business
      Close submenu (Science & Tech) Science & Tech
      • Consumer Technology
      • Energy & Natural Resources
      • Environ­ment
      • Heavy Industry & Manufacturing
      • Telecomm­unications
      Close submenu (Lifestyle & Health) Lifestyle & Health
      • Consumer Products & Retail
      • Entertain­ment & Media
      • Health
      • Sports
      • Travel
      Close submenu (Policy & Public Interest) Policy & Public Interest
      • Policy & Public Interest
      Close submenu (People & Culture) People & Culture
      • People & Culture

      FDA understates percentage of foreign-made medication sold in U.S.

      70% Top 40 Brand-name Drugs Sold in U.S. are Imported; Same Drugs Cost up to 96% Less in Canada


      News provided by

      PharmacyChecker.com

      Nov 08, 2017, 09:23 ET

      Share this article

      Share this article


      WHITE PLAINS, N.Y., Nov. 8, 2017 /PRNewswire/ -- New research from PharmacyChecker.com, an online pharmacy verification and drug price comparison company launched in 2003, has found that the majority of medications sold at local U.S. pharmacies are manufactured abroad and are then sold in the United States with a much higher price tag.

      PharmacyChecker.com's 2nd and 3rd Quarter International Drug Price Savings Reports show that out of 40 popular brand-name drugs sold in the U.S., 70% are imported. The FDA reports that 40% of finished prescription drugs sold in the U.S. are foreign-made. In contrast, as part of its ongoing research, PharmacyChecker.com has found that 28 of the 40 most popular, non-controlled, brand-name drugs sold in the U.S. (as defined by IMS Health data in 2015) are manufactured outside the U.S.

      The PharmacyChecker.com 3rd Quarter International Drug Price Savings Report found 20 popular drugs to be an average of 79% cheaper abroad, with the following average savings per country or group of countries: Canada 67%; Australia/New Zealand/United Kingdom 79%; Turkey 83%; India 82%.

      Recently, the FDA has announced that it will rely on inspection from foreign regulators in Austria, Croatia, France, Italy, Malta, Spain, Sweden and the United Kingdom. These regulatory authorities have been deemed capable—by the FDA—of conducting inspections of manufacturing facilities abroad in line with FDA standards. According to the Government Accountability Office, there are about 1,000 foreign drug manufacturing plants registered with FDA that have never been inspected by the FDA.

      "FDA's data on the percentage of medication sold in the U.S. that is foreign made appears to be wrong or out of date. Our research shows that most of the brand medications Americans buy at their local pharmacies are foreign-made but are often double, even triple the cost compared to the same drugs sold in Canada. Drug importation is legal for pharmaceutical companies, but, regrettably, American consumers face unjust regulatory barriers to accessing lower-cost options from pharmacies outside the U.S. The FDA says buying medication online is not safe, yet we already rely on foreign regulators to protect our drug supply," says Gabriel Levitt, president of PharmacyChecker.com. "Regardless of the law, millions of people buy medication online because drug prices here at home are out of reach. Our international pharmacy verifications and price comparisons provide consumers with information to help them afford medication if they choose to order it online from outside the country."

      The medications analyzed are available online from PharmacyChecker-verified international pharmacies.

      ABOUT PHARMACYCHECKER.COM

      PharmacyChecker.com is the only independent company that verifies international online pharmacies in addition to comparing their prices. We are a stakeholder in the online consumer-driven healthcare community, seeking an open Internet environment that promotes innovation and new business models, especially those that serve the public health.

      Our verifications and price comparisons have been referenced by AARP Magazine, the New York Times, the Wall Street Journal, and many others.

      PharmacyChecker.com International Drug Price Savings Report: 3Q2017

      Medications

      Cost Per Pill (unless otherwise noted)

      Potential Savings vs. USA

      Brand Name (Condition treated)

      Strength

      Country Made In *

      Drug Company

      USA

      CAN

      UK/AUS/NZ

      India

      Turkey

      CAN

      UK/AUS/NZ

      India

      Turkey

      Benicar Olmetec -

      (high blood pressure)

      20 mg

      Japan

      Daiichi Sankyo

      $5.07

      $1.37

      $0.82

      $1.07

      $1.83

      73%

      84%

      79%

      64%

      Benicar HCT Olmetec -

      (high blood pressure)

      40 mg / 25 mg

      Japan

      Daiichi Sankyo

      $8.37

      $1.88

      $1.44

      N/A

      $1.48

      78%

      83%

      N/A

      82%

      Dexilant (heartburn)

      60 mg

      Japan

      Takeda

      $10.46

      $2.78

      $1.58

      N/A

      N/A

      73%

      85%

      N/A

      N/A

      Diovan

      (high blood pressure)

      160 mg

      USA

      Novartis

      $4.42

      $1.79

      $1.15

      $1.07

      $0.60

      60%

      74%

      76%

      86%

      Humalog

      (diabetes)

      100 u/ml

      USA

      Eli Lily

      $292.00

      $47.99

      N/A

      N/A

      N/A

      84%

      N/A

      N/A

      N/A

      Janumet

      (Type 2 diabetes)

      50 / 500mg

      USA

      Merck

      $7.97

      $2.53

      $2.10

      $1.08

      $0.59

      68%

      74%

      86%

      93%

      Lumigan

      (eye pressure)

      0.01%

      Ireland

      Allergan

      $188.00

      $105.00

      $18.97

      $29.00

      N/A

      44%

      90%

      85%

      N/A

      Namenda Ebixa

      (dementia)

      10 mg

      Ireland

      Allergan

      $6.94

      $3.60

      $2.59

      N/A

      $0.75

      48%

      63%

      N/A

      89%

      Namenda XR

      (dementia)

      28 mg.

      Ireland

      Forest Laboratories (Allergan)

      $13.19

      N/A

      N/A

      N/A

      N/A

      N/A

      N/A

      N/A

      N/A

      Novolog

      (diabetes)

      100 u/ml

      Denmark (EU)

      Novo Nordisk

      $316.00

      $47.99

      N/A

      N/A

      N/A

      85%

      N/A

      N/A

      N/A

      Novolog Flexpen

      (diabetes)

      100 iu/ml

      Denmark (EU)

      Novo Nordisk

      $121.80

      $89.99

      N/A

      N/A

      N/A

      26%

      N/A

      N/A

      N/A

      Nuvaring

      (birth control)

      11.4/2.6 mg

      Netherlands

      Merck

      $158.00

      $65.00

      $22.00

      N/A

      $50.00

      59%

      86%

      N/A

      68%

      Ortho-Tri-Cyclen Lo 28

      (birth control)

      0.18 mg/0.025mg, 0.215mg/0.025mg, 0.25mg/0.025mg p

      USA

      Janssen

      $6.36

      $0.89

      N/A

      N/A

      N/A

      86%

      N/A

      N/A

      N/A

      Pataday

      (pink eye)

      2.5 ml

      USA

      Alcon Laboratories

      $207.00

      $68.46

      N/A

      $33.99

      N/A

      67%

      N/A

      84%

      N/A

      Paxil

      (depression)

      20 mg

      Canada

      Bristol-Myers Squibb

      $6.83

      $2.98

      $0.98

      N/A

      $0.70

      56%

      86%

      N/A

      90%

      Premarin tablet

      (menopause)

      3 mg

      Canada

      Pfizer

      $6.45

      $0.29

      $0.77

      $0.94

      N/A

      96%

      88%

      85%

      N/A

      Premarin Cream

      (menopause)

      6.25mg

      Canada

      Pfizer

      $152.00

      $29.99

      N/A

      $16.00

      N/A

      80%

      N/A

      89%

      N/A

      Proventil HFA or Ventolin HFA

      (asthma)

      100 (90) mcg

      USA

      Merck

      $89.00

      $13.99

      $15.00

      N/A

      N/A

      84%

      83%

      N/A

      N/A

      Vesicare

      (overactive bladder)

      10 mg

      Ireland

      Astella Pharma

      $12.57

      $2.92

      $3.72

      N/A

      $1.99

      77%

      70%

      N/A

      84%

      Voltaren Gel

      (arthritis)

      1%

      Germany

      Novartis

      $57.00

      $41.42

      $20.33

      N/A

      N/A

      27%

      64%

      N/A

      N/A


      Average Savings

      67%

      79%

      83%

      82%















      *Applies to medication sold in U.S. pharmacies.

      Sources: Prices were recorded between August and September 2017. U.S. prices shown are retail cash prices listed on GoodRX.com. All other prices are from verified online pharmacies and their price comparisons on PharmacyChecker.com

      SOURCE PharmacyChecker.com

      Modal title

      Contact PR Newswire

      • Call PR Newswire at 888-776-0942
        from 8 AM - 9 PM ET
      • Chat with an Expert
      • General Inquiries
      • Editorial Bureaus
      • Partnerships
      • Media Inquiries
      • Worldwide Offices

      Products

      • Explore Our Platform
      • Plan Campaigns
      • Create with AI
      • Distribute Press Releases
      • Report Results
      • Amplify Content

      About

      • About PR Newswire
      • About Cision
      • Careers
      • Accessibility Statement
      • APAC
      • APAC - Simplified Chinese
      • APAC - Traditional Chinese
      • Brazil
      • Canada
      • Czech
      • Denmark
      • Finland
      • France
      • Germany
      • India
      • Indonesia
      • Israel
      • Italy
      • Japan
      • Korea
      • Mexico
      • Middle East
      • Middle East - Arabic
      • Netherlands
      • Norway
      • Poland
      • Portugal
      • Russia
      • Slovakia
      • Spain
      • Sweden
      • United Kingdom
      • Vietnam

      My Services

      • All New Releases
      • Platform Login
      • Data Privacy

      Do not sell or share my personal information:

      • Submit via [email protected] 
      • Call Privacy toll-free: 877-297-8921

      Contact PR Newswire

      Products

      About

      My Services
      • All News Releases
      • Platform Login
      • ProfNet
      Call PR Newswire at
      888-776-0942
      • Terms of Use
      • Privacy Policy
      • Information Security Policy
      • Site Map
      • RSS
      • Cookies
      Copyright © 2026 Cision US Inc.